Showing 5541-5550 of 5771 results for "".
- Neuro-Optometric Rehabilitation Association (NORA) Launches Redesigned Website; Accepts Award Nominationshttps://modernod.com/news/neuro-optometric-rehabilitation-association-nora-launches-redesigned-website-accepts-award-nominations/2480061/The Neuro-Optometric Rehabilitation Association, International (NORA) announced the launch of its redesigned website and new domain name, www.noravisionrehab.org, dedicated to educating patients, caregivers, and health care professionals about neurolog
- Market Scope: OCT Market to Generate $632 Million in Revenues in 2018https://modernod.com/news/market-scope-oct-market-to-generate-632-million-in-revenues-in-2018/2480062/Market Scope estimates that the optical coherence tomography (OCT) market will generate $632 million in total manufacturer revenues in 2018, and the market will grow to $797 million by 2023 at a compound annual growth rate of 4.8 percent. Market Scope expects much of this growth to come fr
- ThromboGenics Plans Name Change to “Oxurion”https://modernod.com/news/thrombogenics-plans-name-change-to-oxurion/2480064/ThromboGenics announced its intention to change its name to “Oxurion” and the company’s stock ticker symbol from ‘THR” to “OXUR.” The company issued a convening notice seeking the approval of ThromboGenics’ shareholders for the name change at an Extraordinary Genera
- EyeQue Raises $11.2 Million in Series B to Bring At-Home Vision Testing to the Masseshttps://modernod.com/news/eyeque-raises-11-2-million-in-series-b-to-bring-at-home-vision-testing-to-the-masses/2480065/EyeQue announced it has raised $11.2 million in a Series B round from existing investors. The funds will be used to help the company on its mission to eliminate extraneous trips to the optometrist and make at-home vision testing a reality for people across the globe. EyeQue’s patented technology
- New Acucela Data on the Effect of Emixustat Hydrochloride on Retinal Thickness in Diabetic Retinopathyhttps://modernod.com/news/new-acucela-data-on-the-effect-of-emixustat-hydrochloride-on-retinal-thickness-in-diabetic-retinopathy/2480075/Acucela announced new data on the effect of emixustat hydrochloride on retinal thickness in diabetic retinopathy (DR). The study (protocol 4429-203) is a randomized, placebo-controlled, phase 2 clinical trial exploring the effect of oral emixustat hydrochloride in a proliferative diabetic
- ThromboGenics Partners with Prevent Blindness at 2018 Focus on Eye Health National Summit in Washington DChttps://modernod.com/news/thrombogenics-partners-with-prevent-blindness-at-2018-focus-on-eye-health-national-summit-in-washington-dc/2480077/ThromboGenics announced its participation and support of the seventh annual Prevent Blindness Focus on Eye Health National Summit which takes place on July 18, 2018, at the National Press Club in Washington, DC. The Focus on Eye Health National Summit aims to facilitate dialogue around vi
- American Vision Partners Acquires Miles Eye Centerhttps://modernod.com/news/american-vision-partners-acquires-miles-eye-center/2480084/Private Equity-backed American Vision Partners announced a partnership between one of its affiliates, Barnet Dulaney Perkins Eye Center, and Miles Eye Center. Under the name of Barnet Dulaney Perkins Eye Center, patients at Mi
- Bausch + Lomb Launches Soothe Xtra Protection Preservative Free Lubricant Eye Dropshttps://modernod.com/news/bausch-lomb-launches-soothe-xtra-protection-preservative-free-lubricant-eye-drops/2480089/Bausch + Lomb announced the introduction of Soothe Xtra Protection (XP) Preservative Free lubricant eye drops. “Soothe XP Preservative Free provides a new eye drop option for the increasing number of people suffering from dry eye symptoms who are looking for a preservative-free formu
- Shire Launches “Screen Responsibly” Initiative to Prioritize Eye Health in a Screen-Saturated Worldhttps://modernod.com/news/shire-launches-screen-responsibly-initiative-to-prioritize-eye-health-in-a-screen-saturated-world/2480096/Shire announced the launch of “Screen Responsibly,” a new educational initiative about the intersection between screen use and eye health. This initiative is underscored by new national Shire-sponsored survey data and as part of it, a partnership with Thrive Global, a behavior-change
- Nexy Robotic Retinal Imaging System Receives FDA Clearancehttps://modernod.com/news/nexy-robotic-retinal-imaging-system-receive-fda-clearance/2480097/Konan Medical USA announced that the Nexy retinal camera received FDA 510(k) clearance and is now available in the United States. The Nexy features fully robotic operation and is designed for use in ophthalmology, optometry, hospitals, clinics and many other point-of-servic